Please assess the completion status of the following clinical trial:

Trial Title: The OpenAPS_ShadowMode Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* Aged ≥ 18 years~* T1D as defined by WHO for at least 1 year~* Planned use of the Medtronic 670G HCL system~Exclusion Criteria:~* Type 2 diabetes mellitus~* Gestational diabetes mellitus~* Participation in another trial which may in the opinion of the investigator interfere with the software algorithm~* Any mental condition rendering the patient incapable of giving informed consent~* Any disease or condition which in the opinion of the investigator would interfere with the trial performance and/or the physical and/or psychosocial safety of the study participant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 670G/OpenAPS (Type: None): Participants with Type 1 Diabetes wearing a Medtornic Minimed 670G hybrid closed loop system in parallel with a non-insulin injecting, self-constructed OpenAPS system.

Based on this trial design, predict the completion outcome and termination type (if applicable).